Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia

Int J Infect Dis. 2017 Aug:61:23-26. doi: 10.1016/j.ijid.2017.05.013. Epub 2017 May 29.

Abstract

The successful use of tigecycline in a 12-month old liver transplant recipient with extensively drug-resistant Acinetobacter baumannii bacteremia is presented. Tigecycline serum concentrations were monitored to help improve antibiotic efficacy and minimize side effects. A literature review identified 11 additional pediatric cases of A. baumannii infection treated with tigecycline since 2011. Tigecycline treatment should be considered in children with extensively drug-resistant bacterial infections.

Keywords: Tigecycline; XDR Acinetobacter baumannii; bacteremia; pediatric.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii* / drug effects
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Drug Resistance, Bacterial
  • Humans
  • Infant
  • Liver Transplantation
  • Male
  • Minocycline / analogs & derivatives*
  • Minocycline / therapeutic use
  • Tigecycline

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • Minocycline